Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Seidman Cancer Center
11100 Euclid Ave
Cleveland, OH 44106
Summary
- Radiation oncology, Breast Cancer, Tumor Biology, Therapeutic Drugs
Education & Training
- McGill University PhD, 2012 - 2017
- Qingdao University Medical CollegeClass of 2012
Awards, Honors, & Recognition
- Fellow, T32/Translational Research Oncology Training Program NIH/Memorial Sloan-Kettering Cancer Center, 2019-2021
Publications & Presentations
PubMed
- 121 citationsPotent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders.Shang Su, Zimo Yang, Hongying Gao, Haiyan Yang, Songbiao Zhu
Journal of Medicinal Chemistry. 2019-08-02 - 88 citationsKMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.Kinisha Gala, Qing X. Li, Amit U. Sinha, Pedram Razavi, Madeline Dorso
Oncogene. 2018-05-14 - 285 citationsLoss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo PathwayZhiqiang Li, Pedram Razavi, Qing X. Li, Weiyi Toy, Bo Liu
Cancer Cell. 2018-12-10
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: